Autolus Therapeutics (AUTL) Tax Provisions (2017 - 2025)
Autolus Therapeutics posted quarterly Tax Provisions of -$1.2 million for Q4 2025, down 180.92% year-on-year from $1.5 million in Q4 2024, and down 322.37% on a QoQ basis from $532000.0 in Q3 2025.
Autolus Therapeutics (AUTL) has 9 years of Tax Provisions data on file, last reported at -$1.2 million in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions fell 180.92% year-over-year to -$1.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.0 million (up 29.08% YoY), and the FY2025 full-year result was $2.0 million, up 29.06% from the prior year.
- Tax Provisions for Q4 2025 stood at -$1.2 million, down from $532000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $5.4 billion in Q3 2021 and bottomed at -$17.4 million in Q4 2021.
- The 5-year median for Tax Provisions is $31000.0 (2023), against an average of $270.1 million.
- The widest annual swing landed in 2021, when Tax Provisions soared 68367.9%; it then slumped 320.0% in 2023.
- A 5-year view of Tax Provisions shows it stood at -$17.4 million in 2021, then surged by 212.58% to $19.6 million in 2022, then tumbled by 100.12% to -$24000.0 in 2023, then soared by 6191.67% to $1.5 million in 2024, then plunged by 180.92% to -$1.2 million in 2025.
- The last three Tax Provisions figures came in at -$1.2 million (Q4 2025), $532000.0 (Q3 2025), and $397000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 216,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.18 Mn |
| Sep 30, 2025 | 532,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Dec 31, 2023 | -24,000.00 |
| Sep 30, 2023 | -21,000.00 |
| Jun 30, 2023 | 40,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | 19.55 Mn |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -56,000.00 |
| Mar 31, 2022 | -26,000.00 |
| Dec 31, 2021 | -17.37 Mn |
| Sep 30, 2021 | 5.39 Bn |
| Jun 30, 2021 | 6.36 Mn |
| Mar 31, 2021 | 5.72 Mn |
| Dec 31, 2020 | -42.78 Mn |
| Sep 30, 2020 | 7.87 Mn |
| Jun 30, 2020 | 7.02 Mn |
| Mar 31, 2020 | 3.70 Mn |
| Jun 30, 2019 | 3.27 Mn |
| Mar 31, 2019 | 3.42 Mn |
| Sep 30, 2018 | 2.20 Mn |
| Jun 30, 2018 | 2.22 Mn |
| Mar 31, 2018 | 1.47 Mn |
| Dec 31, 2017 | -1.40 Mn |